Establishes a wholesale prescription drug importation program from Canada to provide savings for consumers.
New York S00371 creates a wholesale prescription drug importation program from Canada. The program must comply with federal standards and regulations, ensuring imported drugs meet safety and cost-saving criteria. Only prescription drugs approved by the FDA and not classified as controlled substances or biological products can be imported. The program aims to generate substantial savings for consumers. The commissioner of health, in consultation with the state education department, will design the program and seek necessary federal approvals.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.